Claris plans plant at Bavla campusIllustrative image – not actual.

Claris Lifesciences, the Ahmedabad based pure-play injectables company, has drawn up an investment plan.

The company intends to set up a plant at its 78 acre Bavla campus in Gujarat at a cost of Rs 131 crore to manufacture propofol. The company plans to spend Rs 39 crore on research and development.

Currently, Claris has five plants at its Bavla campus, of which four are operational. The fifth plant that will manufacture finished formulations is slated to become operational within next year.

Related Links:
Project Profile

← All latest storiesBack to top →